Found 64 with Last Name = 'surleraux' and Initial = 'dl' 
Affinity DataKi: 0.0500nM ΔG°: -59.8kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataKi: 0.0500nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 0.100nM ΔG°: -58.0kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataKi: 0.100nM ΔG°: -58.0kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataKi: 0.100nM ΔG°: -58.0kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 0.25nM ΔG°: -55.7kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataKi: 0.25nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 0.300nM ΔG°: -55.3kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataKi: 0.300nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 0.5nM ΔG°: -54.0kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
3D Structure (crystal)Affinity DataKi: 0.5nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 5nM ΔG°: -48.2kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataKi: 9.40nMAssay Description:The aim of this in vitro assay was to measure the inhibition of HCV NS3/4A protease complexes by the compounds of the present invention. This assay p...More data for this Ligand-Target Pair
Affinity DataKi: 9.40nM ΔG°: -46.6kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataKi: 1.00E+3nM ΔG°: -34.8kJ/molepH: 7.5 T: 2°CAssay Description:The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification ...More data for this Ligand-Target Pair
Affinity DataIC50: 10nMAssay Description:Inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 50nMAssay Description:Inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 112nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 178nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 186nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 209nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 219nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 257nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 355nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 372nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 380nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 417nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 417nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 427nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 427nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 427nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 437nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 501nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 562nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 562nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 562nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 631nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 676nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 776nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 813nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+3nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.05E+3nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.41E+3nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.41E+3nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.45E+3nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
Affinity DataIC50: 1.59E+3nMAssay Description:Log of inhibitory concentration against human immunodeficiency virus type 1 integraseMore data for this Ligand-Target Pair
